We work with large and mid-sized pharmaceutical and biotechnology companies as well as emerging specialty firms.
Our team can also support financial and investment firms, including private equity and venture capital, as they build portfolios in the pharmaceutical and biotechnology sectors.
Our experienced principals and consultants can support decision-makers across all levels of your organization, including Sales and Marketing, Decision Sciences, Finance, Corporate Development, and C-Suite executives.
Select Clients
Across multiple projects, Viscadia has listened to our needs and prioritized delivery of key insights that help us gain alignment with the broader team. Their specialization in oncology forecasting has made each forecast creation a breeze, and expanding and updating our models has been seamless. In rapidly changing therapeutic areas, Viscadia's forecasts have withstood the test of time!
Sarah YueAssociate Director
Global Insights
Global Insights
Viscadia brought additional dimensions to the existing forecast, which aided buy-in from our stakeholders. I needed someone to work alongside me, and they were the ideal partner.
Rob HernandezDirector, Forecasting & Financial Planning
Daiichi Sankyo
Daiichi Sankyo
I have worked with Viscadia across many companies and clients. I keep returning to them because they stay on point, grasp and incorporate changes quickly, and their team can provide a different view on market dynamics, rendering the overall output much more robust. The realism in Viscadia’s approach made it extremely easy to communicate to internal stakeholders and ultimately get traction on my projects. I cannot wait to work with them again.
Irina BaramovaCorporate Development
and Strategy
and Strategy
Viscadia has been a long-term strategic partner to Milestone on the forecasting front. In addition to their responsiveness and innovative modeling techniques, they have deep therapeutic expertise which enables us to expand our own thinking and ultimately make more informed decisions.
Lorenz MullerChief Commercial Officer
Milestone Pharmaceuticals
Milestone Pharmaceuticals
"Our forecast was accurate... that was a critical piece of allowing us to complete a successful and valuable acquisition."
